Credit Agricole’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Credit Agricole’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,000	Closed	-$40K	–	766
2021 Q1	$40K	Hold	18,000	–	–	﹤0.01%	474
2020 Q4	$45K	Hold	18,000	–	–	﹤0.01%	407
2020 Q3	$44K	Hold	18,000	–	–	﹤0.01%	375
2020 Q2	$64K	Hold	18,000	–	–	﹤0.01%	309
2020 Q1	$42K	Hold	18,000	–	–	﹤0.01%	331
2019 Q4	$40K	Hold	18,000	–	–	﹤0.01%	328
2019 Q3	$33K	Hold	18,000	–	–	﹤0.01%	399
2019 Q2	$26K	Hold	18,000	–	–	﹤0.01%	409
2019 Q1	$35K	Buy	+18,000	New	+$38.2K	﹤0.01%	395

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Credit Agricole's NYMX Position: Q2 2021 in Review

Credit Agricole sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 18,000 shares — an estimated $40K sold.

Credit Agricole first reported a position in NYMX in Q1 2019 and held it in 9 quarters. The position peaked at $64K in Q2 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

Credit Agricole reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
Credit Agricole sold 18,000 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $40K.
Credit Agricole first reported a position in Nymox Pharmaceutical Corp in Q1 2019 and held it in 9 quarters.
Credit Agricole's Nymox Pharmaceutical Corp position peaked at $64K in Q2 2020.
51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Credit Agricole's 13F filing for Q2 2021, filed 10 Aug 2021.